Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Home | Events | Functional validation of DNA glycosylases as cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Potential use of OGG1 inhibitors as a novel strategy for cancer treatment

Functional validation of DNA glycosylases as cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Potential use of OGG1 inhibitors as a novel strategy for cancer treatment

Information

Date: 29/01/2021
Time 11:00
Venue: Online
Conference Speaker Juan Miguel Baquero
Institution Human Genetics Group, Human Cancer Genetics Programme
Supervised by Javier Benítez and Ana Osorio, Human Genetics Group, Human Cancer Genetics Programme
Free admission until full capacity is reached

Up